BOSTON,MA (January 8, 2020)—Cure Rare Disease (CRD), the emerging, Boston-based nonprofit on a mission to develop precision medicine for rare diseases, is pleased to provide an annual review of its activities and accomplishments in 2019. Successful fundraising efforts have all...

San Francisco (California) January 6, 2020: NanoValent Pharmaceuticals, Inc., a development stage, cancer focused pharmaceutical company progressing a new class of targeted nanosphere therapeutics, today announced the publication of United States Patent No. 10,369,104 from the...

CES 2020, LAS VEGAS, Nevada, USA – Jan. 8, 2020 - Ceres Holographics, an innovative developer of thin-film Holographic Optical Elements (HOEs) for next-generation transparent display (TD) and augmented reality head-up-display (AR-HUD) solutions, today announced its latest TD p...

BOSTON, MA — January 8, 2020 — NanoView Biosciences, Inc., today announced that Jerry Williamson, Chief Executive Officer, is scheduled to present at Biotech Showcase™ 2020 taking place on January 13-15, 2020 at the Hilton San Francisco Union Square, San Francisco, CA. NanoVie...

Salt Lake City, Utah/Jan. 8, 2020 – Light Line MedicalTM, Inc. today announced that it has been invited to present at Biotech Showcase™ 2020, to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square. Vicki Farrar, CEO, wi...

DOYLESTOWN, Pa., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, announced today the receipt of a designated International Nome...

[New York] – EpiVax Oncology, Inc, today announced that it has scheduled a company presentation at Biotech Showcase™ 2020, to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square. Gad Berdugo, CEO will present at Biotech ...

January 7, 2020 -- Nantes, France – InFlectis BioScience SAS, a drug discovery company committed to the development of innovative therapeutics harnessing the Integrated Stress Response for the treatment of a broad range of diseases, today announced the results of its Phase 1 s...

Chicago, Il. January 8, 2020: Content Carnivores, LLC, a creative marketing firm deploying proprietary technology, category and creative expertise in regulated industries is supporting 10 clients who are participating at the Biotech Showcase™ 2020, investor conference and/or o...

Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an unmet kidney disease indication, today announced that it will present at Biotech Showcase™ 2020, to be held January 13–15, 2020 at the Hilton San Francisco ...